The maiden investment round was backed by the British Design Fund and angel investors including Tom Blomfield.
"This funding is not only a huge vote of confidence in PEEQUAL but also a big moment for pee equality the world over. We want PEEQUAL to empower women to take back their time and break the taboo around female urination. We are building a team to bring our urinals to festivals, sporting events, outdoor shows and more. We’re really proud to be changing the way women pee, and doing it in a safe way which reduces time spent in queues."
The funding round includes backing from strategic and regional investors to support the rollout of Female Hormone Mapping.
"Today, more and more people are realising that understanding and measuring your body’s biochemistry is key for a long and healthy life. For women in particular, gaining unique insight into how their hormone levels fluctuate throughout their unique cycle can give women the support they have been lacking and help to close the gender health gap"
The extension round includes backing from Blume Equity and existing investors to support the brand's growth.
"Elvie is ready for the next phase of our growth. We have already revolutionized the categories we operate in, but we know that there is vast untapped potential to create better technology products and services for women in new areas."
The Series C round was led by BGF with participation from BlackRock, Hiro Capital, Westerly Winds, Octopus Ventures and IPGL.
"Elvie has already revolutionized every category it has entered – but we know that we have barely scratched the surface of what is possible for women’s tech."
